Legend: CC = Colorado Convention Center H = Hyatt Regency Denver at Colorado Convention Center
Activity Details
240
Mon, 7/29/2019,
2:00 PM -
3:50 PM
CC-705
Topics in Multiplicity and Control of False Discovery Rate — Contributed Papers
Biopharmaceutical Section
Chair(s): Huichao Chen, Harvard University
2:05 PM
Optimizing Graphical Procedures for Multiplicity Control in a Confirmatory Clinical Trial via Deep Learning
Tianyu Zhan, Immunology, DSS, AbbVie ; Alan Hartford, Takeda Pharmaceutical Company; Jian Kang, University of Michigan; Walt Offen, Retired
2:20 PM
Application of Discrete False Discovery Rate Controlling Procedures in Clinical Safety Evaluations
Li He, Merck Research Laboratories ; Joe Heyse, Merck
2:35 PM
Credible Subgroups for Identifying Benefiting Populations with Time-To-Event Data
Duy Ngo ; Richard Baumgartner, Merck Research Laboratories; Shahrul Mt-Isa, MSD; Dai Feng, AbbVie; Jie Chen, Merck Research Laboratories; Joe Heyse, Merck; Patrick Schnell, Ohio State University
2:50 PM
A General Solution to Multiple Hypothesis Testing Problem with Constraints
Huajiang Li, Allergan ; Hong Zhou, Arkansas State University
3:05 PM
Incorporating the Sample Correlation Between Two Test Statistics to Adjust the Critical Points for the Control of Type-1 Error
Dror Rom, Prosoft Clinical ; Jaclyn Ashley McTague, Prosoft Clinical
3:20 PM
MULTIPLE TESTING METHODS for A-PRIORI ORDERED HYPOTHESES
Anjana Grandhi, Merck & Co.
3:35 PM
An Extended Simes Test Procedure for Multiple Testing
Matthew Hudson, Prosoft Clinical ; Dr. Joshua Naranjo, Western Michigan University; Dror Rom, Prosoft Clinical
